
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway
Chang Bao, Tao Liu, Ling-Bo Qian, et al.
Journal of Cancer (2020) Vol. 12, Iss. 1, pp. 76-88
Open Access | Times Cited: 41
Chang Bao, Tao Liu, Ling-Bo Qian, et al.
Journal of Cancer (2020) Vol. 12, Iss. 1, pp. 76-88
Open Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
Shikonin, a naphthalene ingredient: Therapeutic actions, pharmacokinetics, toxicology, clinical trials and pharmaceutical researches
Qiang Sun, Ting Gong, Maolun Liu, et al.
Phytomedicine (2021) Vol. 94, pp. 153805-153805
Closed Access | Times Cited: 95
Qiang Sun, Ting Gong, Maolun Liu, et al.
Phytomedicine (2021) Vol. 94, pp. 153805-153805
Closed Access | Times Cited: 95
Fe(III)‐Shikonin Supramolecular Nanomedicine for Combined Therapy of Tumor via Ferroptosis and Necroptosis
Wenjie Feng, Wanrui Shi, Shuwei Liu, et al.
Advanced Healthcare Materials (2021) Vol. 11, Iss. 2
Closed Access | Times Cited: 63
Wenjie Feng, Wanrui Shi, Shuwei Liu, et al.
Advanced Healthcare Materials (2021) Vol. 11, Iss. 2
Closed Access | Times Cited: 63
Traditional Chinese Medicine and Colorectal Cancer: Implications for Drug Discovery
Qiang Sun, Man He, Meng Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 57
Qiang Sun, Man He, Meng Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 57
PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds
Yeqin Yuan, Hui‐Zhi Long, Ziwei Zhou, et al.
Biomolecules (2023) Vol. 13, Iss. 1, pp. 93-93
Open Access | Times Cited: 37
Yeqin Yuan, Hui‐Zhi Long, Ziwei Zhou, et al.
Biomolecules (2023) Vol. 13, Iss. 1, pp. 93-93
Open Access | Times Cited: 37
Inhibition of IKK complex by (2 methyl butyryl) Shikonin, a naturally occurring naphthoquinone, abrogates melanoma growth and progression via modulation of the IKK/NFκB /EMT signaling axis
Aalim Maqsood Bhat, Irshad Ahmad Bhat, Minnie Malik, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114026-114026
Closed Access
Aalim Maqsood Bhat, Irshad Ahmad Bhat, Minnie Malik, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114026-114026
Closed Access
Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action
Mehdi Valipour
European Journal of Medicinal Chemistry (2022) Vol. 235, pp. 114314-114314
Closed Access | Times Cited: 29
Mehdi Valipour
European Journal of Medicinal Chemistry (2022) Vol. 235, pp. 114314-114314
Closed Access | Times Cited: 29
Uncarboxylated osteocalcin induced miR-143-3p targets SP7 and activates PI3K/Akt signaling in TNBC cells to promote invasion and migration
Qian Du, Jiaojiao Xu, Miao Zhang, et al.
Translational Oncology (2025) Vol. 53, pp. 102305-102305
Open Access
Qian Du, Jiaojiao Xu, Miao Zhang, et al.
Translational Oncology (2025) Vol. 53, pp. 102305-102305
Open Access
Resveratrol contributes to NK cell-mediated breast cancer cytotoxicity by upregulating ULBP2 through miR-17-5p downmodulation and activation of MINK1/JNK/c-Jun signaling
Bisha Ding, Jie Li, Jia-Lin Yan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Bisha Ding, Jie Li, Jia-Lin Yan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Shikonin induces apoptosis and autophagy via downregulation of pyrroline-5-carboxylate reductase1 in hepatocellular carcinoma cells
Junli Zhang, Ling Shang, Wendi Jiang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7904-7918
Open Access | Times Cited: 26
Junli Zhang, Ling Shang, Wendi Jiang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7904-7918
Open Access | Times Cited: 26
Pharmacological and analytical aspects of alkannin/shikonin and their derivatives: An update from 2008 to 2022
Kirandeep Kaur, Rashi Sharma, Atamjit Singh, et al.
Chinese Herbal Medicines (2022) Vol. 14, Iss. 4, pp. 511-527
Open Access | Times Cited: 22
Kirandeep Kaur, Rashi Sharma, Atamjit Singh, et al.
Chinese Herbal Medicines (2022) Vol. 14, Iss. 4, pp. 511-527
Open Access | Times Cited: 22
Unraveling Therapeutic Opportunities and the Diagnostic Potential of microRNAs for Human Lung Cancer
Osama Sweef, Elsayed Zaabout, Ahmed Bakheet, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2061-2061
Open Access | Times Cited: 14
Osama Sweef, Elsayed Zaabout, Ahmed Bakheet, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2061-2061
Open Access | Times Cited: 14
Recent advancement in developing small molecular inhibitors targeting key kinase pathways against triple-negative breast cancer
Rajibul Islam, Khor Poh Yen, Nur Najihah Izzati Mat Rani, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117877-117877
Open Access | Times Cited: 3
Rajibul Islam, Khor Poh Yen, Nur Najihah Izzati Mat Rani, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117877-117877
Open Access | Times Cited: 3
Exosomal miR ‐374c‐5p derived from mesenchymal stem cells suppresses epithelial‐mesenchymal transition of hepatocellular carcinoma via the LIMK1‐Wnt /β‐catenin axis
Bisha Ding, Weiyang Lou, Weimin Fan, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 5, pp. 1038-1052
Closed Access | Times Cited: 9
Bisha Ding, Weiyang Lou, Weimin Fan, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 5, pp. 1038-1052
Closed Access | Times Cited: 9
The effects of the tumor suppressor gene PTEN on the proliferation and apoptosis of breast cancer cells via AKT phosphorylation
Junhua Zhang, Ying Zhang, Xiaomeng Lin, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 7, pp. 1863-1872
Open Access | Times Cited: 8
Junhua Zhang, Ying Zhang, Xiaomeng Lin, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 7, pp. 1863-1872
Open Access | Times Cited: 8
Shikonin-Loaded Hollow Fe-MOF Nanoparticles for Enhanced Microwave Thermal Therapy
Lufeng Chen, Dongming Zhao, Xiangling Ren, et al.
ACS Biomaterials Science & Engineering (2023) Vol. 9, Iss. 9, pp. 5405-5417
Open Access | Times Cited: 8
Lufeng Chen, Dongming Zhao, Xiangling Ren, et al.
ACS Biomaterials Science & Engineering (2023) Vol. 9, Iss. 9, pp. 5405-5417
Open Access | Times Cited: 8
Deciphering the landscape of triple negative breast cancer from microenvironment dynamics and molecular insights to biomarker analysis and therapeutic modalities
Harshita Tiwari, Swati Singh, Sonal Sharma, et al.
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 2
Harshita Tiwari, Swati Singh, Sonal Sharma, et al.
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 2
Shikonin Stimulates Mitochondria‐Mediated Apoptosis by Enhancing Intracellular Reactive Oxygen Species Production and DNA Damage in Oral Cancer Cells
Stuti Biswal, Munmun Panda, Bijesh K. Biswal
Journal of Cellular Biochemistry (2024)
Open Access | Times Cited: 2
Stuti Biswal, Munmun Panda, Bijesh K. Biswal
Journal of Cellular Biochemistry (2024)
Open Access | Times Cited: 2
Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling Pathway
Sascha D. Markowitsch, Olesya Vakhrusheva, Patricia Schupp, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1114-1114
Open Access | Times Cited: 12
Sascha D. Markowitsch, Olesya Vakhrusheva, Patricia Schupp, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1114-1114
Open Access | Times Cited: 12
Hyaluronic acid-coated shikonin liposomes for the treatment of triple-negative breast cancer via targeting tumor cells and amplification of oxidative stress
Luhua Meng, Jin Ren, Zhen Liu, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 70, pp. 103193-103193
Closed Access | Times Cited: 12
Luhua Meng, Jin Ren, Zhen Liu, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 70, pp. 103193-103193
Closed Access | Times Cited: 12
Potential Epigenetic Modifications Implicated in Triple- To Quadruple-Negative Breast Cancer Transition: A Review
Aliyu Muhammad, Gilead Ebiegberi Forcados, Babangida Sanusi Katsayal, et al.
Epigenomics (2022) Vol. 14, Iss. 11, pp. 711-726
Closed Access | Times Cited: 12
Aliyu Muhammad, Gilead Ebiegberi Forcados, Babangida Sanusi Katsayal, et al.
Epigenomics (2022) Vol. 14, Iss. 11, pp. 711-726
Closed Access | Times Cited: 12
Blood Plasma Small Non-Coding RNAs as Diagnostic Molecules for the Progesterone-Receptor-Negative Phenotype of Serous Ovarian Tumors
Angelika V. Timofeeva, Ivan S. Fedorov, A.V. Asaturova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12214-12214
Open Access | Times Cited: 7
Angelika V. Timofeeva, Ivan S. Fedorov, A.V. Asaturova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12214-12214
Open Access | Times Cited: 7
Shikonin induces cell autophagy via modulating the microRNA -545-3p/guanine nucleotide binding protein beta polypeptide 1 axis, thereby disrupting cellular carcinogenesis in colon cancer
Zhiwei Hu, XinDong Zhou, Deqiang Zeng, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 5928-5941
Open Access | Times Cited: 11
Zhiwei Hu, XinDong Zhou, Deqiang Zeng, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 5928-5941
Open Access | Times Cited: 11
Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response
Mehrdokht Sadrkhanloo, Maliheh Entezari, Mohsen Rashidi, et al.
European Journal of Pharmacology (2022) Vol. 932, pp. 175212-175212
Closed Access | Times Cited: 11
Mehrdokht Sadrkhanloo, Maliheh Entezari, Mohsen Rashidi, et al.
European Journal of Pharmacology (2022) Vol. 932, pp. 175212-175212
Closed Access | Times Cited: 11
Anti-Cancer Potential of Phytochemicals: The Regulation of the Epithelial-Mesenchymal Transition
S Y Liu, Lingyu Li, Dong‐Mei Ren
Molecules (2023) Vol. 28, Iss. 13, pp. 5069-5069
Open Access | Times Cited: 6
S Y Liu, Lingyu Li, Dong‐Mei Ren
Molecules (2023) Vol. 28, Iss. 13, pp. 5069-5069
Open Access | Times Cited: 6
MicroRNAs in Epithelial–Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy
Fu Peng, Huali Fan, Li Sui, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7526-7526
Open Access | Times Cited: 14
Fu Peng, Huali Fan, Li Sui, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7526-7526
Open Access | Times Cited: 14